Introduction {#s1}
============

In the United States, non-typhoidal *Salmonella enterica* subsp. *enterica* cause an estimated one million episodes of salmonellosis each year [@pone.0077836-Scallan1] and are the leading cause of hospitalization and death from foodborne illness. The resulting annual economic burden, based on the costs of medical treatment, lost productivity and premature death, is estimated to be in the range of \$3.3-4.4 billion [@pone.0077836-Hoffmann1], [@pone.0077836-Scharff1].

PulseNet is the national molecular surveillance network for foodborne infections and includes in its network the laboratories of state, territorial, and local public health departments, federal food regulatory agencies, veterinary agencies, and agricultural agencies. PulseNet was established by the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories in 1996 to reduce the time needed to detect, investigate, and control multistate outbreaks caused by foodborne bacterial pathogens. PulseNet laboratories subtype these pathogens using pulsed-field gel electrophoresis (PFGE) and upload the PFGE patterns to a centralized database at CDC [@pone.0077836-Swaminathan1], [@pone.0077836-GernerSmidt1].

The National Antimicrobial Resistance Monitoring System (NARMS) is a national public health surveillance system that tracks antimicrobial resistance in foodborne bacteria. The NARMS program was established in 1996 as a partnership between the U.S. Food and Drug Administration (FDA), CDC, and the U.S. Department of Agriculture (USDA) and is described on the FDA website [@pone.0077836-National1]. The animal arm of NARMS resides in the USDA-Agricultural Research Service (ARS) laboratory in Athens, GA. In addition to monitoring antimicrobial susceptibility, NARMS partners collaborate on epidemiologic and microbiologic research studies. NARMS also examines foodborne bacteria for genetic relatedness using PFGE, and PFGE patterns are entered into USDA's VetNet database [@pone.0077836-Jackson1]. The food animal arm of NARMS is described on the USDA web site [@pone.0077836-National2]. PulseNet and VetNet work synergistically to provide information that is important for public health. The PFGE protocols are highly standardized protocols developed by PulseNet to facilitate inter-laboratory comparisons [@pone.0077836-Ribot1].

As part of communicable disease control reporting requirements in Pennsylvania, clinical laboratories routinely submit *Salmonella* isolates to the Pennsylvania Department of Heath Bureau of Laboratories (BOL). At BOL, Salmonella isolates are biochemically identified, serotyped and subtyped by PFGE. USDA's Food Safety and Inspection Service (FSIS) samples food animals for *Salmonella* during slaughter and processing. *Salmonella* isolates from food animals are tested for susceptibility to antimicrobial agents and then subtyped via PFGE by the USDA-ARS Laboratory in Athens, Georgia.

Our objective was to compare clinical isolates of non-typhoidal *Salmonella* recovered from humans (human *Salmonella*) received as part of routine surveillance at the BOL in Pennsylvania from 2005 through 2011 with *Salmonella* isolates recovered during the same period from food animals (food animal *Salmonella*) at slaughter and processing facilities in the northeastern United States. The most common PFGE patterns observed in human *Salmonella* served as the reference set and included associated invasiveness and antimicrobial susceptibility profiles. Our hypothesis was that subtyping *Salmonella* isolates by PFGE could reveal differences within serotypes in terms of antimicrobial susceptibility patterns and, for human *Salmonella*, differences in food animal sources and invasiveness that were not evident from serotyping alone.

Materials and Methods {#s2}
=====================

Sample Sources and Processing {#s2a}
-----------------------------

Human and food animal non-typhoidal *Salmonella* isolates received between January 1, 2005 and December 31, 2011, were included in the study. At BOL, human *Salmonella* isolates received as part of the state's routine operations were grown, identified, and serotyped by the Bacteriology Section, using standard procedures [@pone.0077836-Brenner1], [@pone.0077836-FarmerIII1]. Food animal *Salmonella* isolates were recovered from carcass rinsates (chickens), carcass swabs (turkeys, cattle, and swine), and ground products (chicken, turkey, and beef) during slaughter and processing at federally inspected facilities in the northeast (Pennsylvania, Maine, Vermont, New Hampshire, New York, Maryland, Connecticut, Rhode Island, Massachusetts, Delaware, New Jersey, Indiana, Ohio, Michigan and Washington, DC) as previously described [@pone.0077836-USD1].

PFGE testing of human *Salmonella* isolates was conducted by the BOL according to the CDC-standardized procedure used by all PulseNet-certified laboratories [@pone.0077836-Ribot1]. Gel images were analyzed using BioNumerics software Version 6.6 (Applied Maths, Saint-Martens-Latem, Belgium). All non-typhoidal human *Salmonella* isolates received at the BOL were evaluated by PFGE, except when the same serotype of *Salmonella* was recovered more than once from a patient within a six-month period. In this case, only the first isolate received was tested. PFGE testing of food animal *Salmonella* isolates was done by the animal arm of the NARMS, located in Athens, GA, as previously described [@pone.0077836-Jackson1].

PFGE Pattern Names {#s2b}
------------------

PFGE fingerprints of human *Salmonella* were maintained in a local Pennsylvania database and submitted to CDC's PulseNet national *Salmonella* database where they were assigned pattern names [@pone.0077836-Swaminathan1], [@pone.0077836-GernerSmidt1]. The USDA maintains a similar database called USDA-VetNet for PFGE fingerprints of *Salmonella* isolated from food animals [@pone.0077836-Jackson1]. Food animal *Salmonella* pattern names were assigned by USDA-VetNet as previously described [@pone.0077836-Jackson1]. Isolates in the VetNet database were compared to the PulseNet database to capture matching PulseNet pattern names.

Common Human *Salmonella* Patterns and Shared Common Patterns {#s2c}
-------------------------------------------------------------

The 20 most frequently identified PFGE patterns among human *Salmonella* isolates and with at least two isolates in each year of the study were designated as the most common human *Salmonella* patterns. These 20 patterns included patterns that occurred both sporadically (n = 4,471) and linked to known outbreaks (n = 251). The USDA-VetNet database was then searched for matching patterns in *Salmonella* isolates recovered from food animals during slaughter and processing in northeastern U.S. facilities. The most common human patterns that were also identified in food animal *Salmonella* and are defined here as "shared common patterns."

Antimicrobial Susceptibility Testing {#s2d}
------------------------------------

Susceptibility to the following classes of antimicrobial agents was tested using the Sensititre semi-automated broth microdilution antimicrobial susceptibility system (Trek Diagnostic Systems Inc., Cleveland, Ohio), with minimum inhibitory concentrations evaluated according to Clinical Laboratory Standards Institute (CLSI) guidelines [@pone.0077836-Clinical1]: (antimicrobial agents in parentheses; resistance breakpoints in brackets): aminoglycosides (amikacin \[≥64 µg/mL\], gentamicin \[≥16 µg/mL\], kanamycin \[≥64 µg/mL\] and streptomycin \[≥64 µg/mL\]), ß-lactam/ß-lactamase inhibitor combinations (amoxicillin/clavulanic acid \[≥32/16 µg/mL\]), cephems (cefoxitin \[≥32 µg/mL\], ceftiofur \[≥8 µg/mL\] and ceftriaxone \[≥4 µg/mL\]), penicillins (ampicillin \[≥32 µg/mL\]), quinolones (ciprofloxacin \[≥4 µg/mL\]and nalidixic acid \[≥32 µg/mL\]), folate pathway inhibitors (sulfisoxazole \[≥512 µg/mL\], trimethoprim/sulfamethoxazole \[≥4/76 µg/mL\]), phenicols (chloramphenicol \[≥32 µg/mL\]), and tetracyclines (tetracycline \[≥16 µg/mL\]). For antimicrobial agents without CLSI approved standards, NARMS interpretive criteria as established by the NARMS working group were used and quality control strains were as previously described [@pone.0077836-National2]. Multidrug resistance was defined as resistance to three or more classes of antimicrobial agents. Of the 4,235 human *Salmonella* isolates with common shared patterns, 467 (11%) were tested for susceptibility to antimicrobial agents. Limited resources precluded testing all of the isolates. The isolates chosen for susceptibility testing included 267 randomly selected isolates originating from Pennsylvania that were tested by the human arm of NARMS as part of its routine surveillance program [@pone.0077836-Centers1]. The Pennsylvania Department of Agriculture tested an additional 200 human *Salmonella* isolates sampled from the 16 shared common patterns. NARMS tested all 275 of the food animal *Salmonella* isolates having shared common patterns for antimicrobial susceptibility as previously described [@pone.0077836-USD1].

Correlation of Invasiveness with PFGE Patterns {#s2e}
----------------------------------------------

Isolation of *Salmonella* from human blood was used as an indicator of invasive disease [@pone.0077836-Vugia1]. The statistical association between each PFGE pattern and invasiveness was tested via a 2×2 contingency table and evaluated on the basis of the conditional maximum likelihood estimate of Odds Ratio (OR) and the mid-p test (two-tailed p value) [@pone.0077836-Dean1]. PFGE patterns with OR≥1 and p≤0.05 were interpreted as associated with increased invasiveness; patterns with OR≤1 and p≤0.05 were interpreted as associated with decreased invasiveness.

Correlation of Antimicrobial Resistance with Invasiveness {#s2f}
---------------------------------------------------------

A two-tailed p value obtained with a Fisher's exact test (GraphPad QuickCalcs, GraphPad Software, Inc., San Diego, CA) was used to evaluate the relationship between antimicrobial resistance and invasiveness.

Regarding data for *Salmonella* recovered from animals: ACUC approval was not needed as the isolates were obtained as part of the National Antimicrobial Resistance Monitoring System (NARMS) from the USDA Food Safety and Inspection Service (FSIS) as part of their Salmonella PR/HACCP verification testing program (<http://www.ars.usda.gov/Main/docs.htm?docid=6750&page=2>). Accessed 2013 September 19.

Results {#s3}
=======

PFGE Patterns Found both in Human and Food Animal *Salmonella* Isolates {#s3a}
-----------------------------------------------------------------------

A total of 11,967 human *Salmonella* and 2,187 food animal *Salmonella* isolates were submitted for laboratory testing during the study period (2005--2011). The food animal *Salmonella* isolates were recovered from a total of 65,655 animals tested for *Salmonella* during slaughter and processing at federally inspected facilities in the northeastern U.S., and represented an overall yield of 3.3% ([Table 1](#pone-0077836-t001){ref-type="table"}). The 65,655 animals tested for *Salmonella* included 42,368 (64.5%) cattle, 10,412 (15.9%) swine, 9,661(14.7%) chickens and 3,214 (4.9%) turkeys. *Salmonella* was isolated from a total of 2,187 samples ([Table 1](#pone-0077836-t001){ref-type="table"}). Of the 2,187 *Salmonella-*positive samples, 1,194 (54.6%) were recovered from chickens, 472 (21.6%) from cattle, 282 (12.9%) from turkeys and 239 (10.9%) from swine. A total of 2,083 of the 2,187 food animal *Salmonella* isolates were available to VetNet for PFGE, antimicrobial susceptibility testing and comparison with human *Salmonella* isolates.

10.1371/journal.pone.0077836.t001

###### Food Animal Sources of *Salmonella* Recovered at Federally Inspected Slaughter and Processing Facilities in the Northeastern U.S.[1](#nt101){ref-type="table-fn"} with Human Isolates Shown for Reference.

![](pone.0077836.t001){#pone-0077836-t001-1}

  Year     No. Chickens Tested   No. (%) Chickens Positive for *Salmonella*   No. Cattle Tested   No. (%) Cattle Positive for *Salmonella*   No. Turkeys Tested   No. (%)TurkeysPositive forSalmonella   No. Swine Tested   No. (%) Swine Positive for *Salmonella*   Total No. Samples Inspected   Total No. (%) Positive for *Salmonella*   No. Human Salmonella Received   No. 20 Most Common Human *Salmonella*
  ------- --------------------- -------------------------------------------- ------------------- ------------------------------------------ -------------------- -------------------------------------- ------------------ ----------------------------------------- ----------------------------- ----------------------------------------- ------------------------------- ---------------------------------------
  2005            1714                           315 (18.4)                         9,754                        102 (1.0)                          175                        39 (22.3)                      2,191                        61 (2.8)                             13,834                             517 (3.7)                              1,537                                549
  2006            1,947                          271 (13.9)                         8,449                        117 (1.4)                          730                        74 (10.1)                      2,346                        78 (3.3)                             13,472                             540 (4.0)                              1,686                                749
  2007            1,684                          172 (10.2)                         6,539                         76 (1.2)                          709                         49 (6.9)                      1,643                        27 (1.6)                             10,575                             324 (3.1)                              1,829                                706
  2008            1,002                          103 (10.3)                         6,241                         90 (1.4)                          276                        43 (15.6)                      1,342                        26 (1.9)                              8,861                             262 (3.0)                              1,680                                645
  2009             989                            95 (9.6)                          4,005                         19 (0.5)                          376                         29 (7.7)                      1,099                        13 (1.2)                              6,469                             156 (2.4)                              1,706                                662
  2010            1,254                          146 (11.6)                         3,099                         29 (0.9)                          573                         38 (6.6)                      1,137                        24 (2.1)                              6,063                             237 (3.9)                              1,749                                716
  2011            1,071                           92 (8.6)                          4,281                         39 (0.9)                          375                         10 (2.7)                       654                         10 (1.5)                              6,381                             151 (2.4)                              1,778                                695
  TOTAL           9,661                         1,194 (12.4)                       42,368                        472 (1.1)                         3,214                       282 (8.8)                      10,412                       239 (2.3)                            65,655                            2,187 (3.3)                            11,967                               4722

Pennsylvania, Maine, Vermont, New Hampshire, New York, Maryland, Connecticut, Rhode Island, Massachusetts, Delaware, New Jersey, Indiana, Ohio, Michigan and Washington, DC.

Common Human *Salmonella* Patterns {#s3b}
----------------------------------

The 20 most common human *Salmonella* XbaI patterns are shown in [Fig. 1](#pone-0077836-g001){ref-type="fig"} and described in [Table 2](#pone-0077836-t002){ref-type="table"}. These patterns represent 39% of the human *Salmonella* isolates (4,722/11,967) from Pennsylvania described in this paper. Six serotypes--Berta, Enteritidis, Heidelberg, Newport, Thompson, and Typhimurium (including variant 5-)--and one antigenic formula (I 4,[@pone.0077836-GernerSmidt1],12:i:-) were represented among these 20 patterns. Each XbaI pattern is shown with all associated BlnI patterns that occurred at least three times in the dataset. One to seven different BlnI patterns were associated with a particular XbaI pattern.

![DNA fingerprints of the 20 most common human *Salmonella* patterns.\
PFGE was conducted as described in Materials and Methods, with restriction endonucleases XbaI and BlnI. BlnI patterns represented at least three times in the dataset are shown.](pone.0077836.g001){#pone-0077836-g001}

10.1371/journal.pone.0077836.t002

###### Pennsylvania's Most Common Human *Salmonella* PFGE Patterns Also Found in *Salmonella* Recovered from Food Animals Processed in the Northeastern U.S.

![](pone.0077836.t002){#pone-0077836-t002-2}

  Serotype                                               PulseNet XbaI Pattern[1](#nt102){ref-type="table-fn"}   No. (% of All Human *Salmonella*)[2](#nt104){ref-type="table-fn"}   No.Linked toOutbreaks   No. from Blood   \% from Blood within Pattern[3](#nt105){ref-type="table-fn"}   Association ofPFGE Pattern withBlood[3](#nt105){ref-type="table-fn"} Odds Ratio(95% CI); p     CorrespondingVetNet Pattern[4](#nt107){ref-type="table-fn"}      No. (%)[5](#nt108){ref-type="table-fn"}of FoodAnimal*Salmonella*   No.fromCattle   No.fromChicken   No.fromSwine   No.fromTurkey
  ----------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------------------- ----------------------- ---------------- -------------------------------------------------------------- -------------------------------------------------------------------------------------------- ------------------------------------------------------------------ ------------------------------------------------------------------ --------------- ---------------- -------------- ---------------
  Berta                                                                       JAXX01.0001                                                    49 (0.41)                                         0                   5                                     10.20                                                                 2.00 (0.70-4.75); 0.17                                                             JAXX01.0003 ARS                                                        3 (0.14)                                     0               0               0               3
  Enteritidis                                                                 JEGX01.0002                                                   235 (1.96)                                         3                   14                                     5.96                                                                 1.11 (0.62-1.87); 0.68                                                             JEGX01.0017 ARS                                                           0                                         0               0               0               0
  Enteritidis                                                                 JEGX01.0004                                                  1,968 (16.45)                                      79                  130                                     6.61                                                                 1.30 (1.06-1.58); 0.01                                                             JEGX01.0003 ARS                                                       106 (5.09)                                    1              105              0               0
  Enteritidis                                                                 JEGX01.0005                                                   426 (3.56)                                        12                   35                                     8.22                                                                 1.60 (1.11-2.26); 0.01                                                             JEGX01.0002 ARS                                                       65 (3.12)                                     1               64              0               0
  Enteritidis                                                                 JEGX01.0009                                                   144 (1.20)                                         1                   15                                    10.42                                                                 2.06 (1.16-3.46); 0.02                                                             JEGX01.0022 ARS                                                           0                                         0               0               0               0
  Enteritidis                                                                 JEGX01.0021                                                   331 (2.77)                                        24                   21                                     6.34                                                                 1.19 (0.74-1.84); 0.43                                     JEGX01.0010 ARS; JEGX01.0052 ARS[6](#nt109){ref-type="table-fn"}                               1 (0.05)                                     0               1               0               0
  Enteritidis                                                                 JEGX01.0034                                                   176 (1.47)                                        11                   1                                      0.57                                                                 0.10 (0.00-0.49); 0.00                                                             JEGX01.0005 ARS                                                       14 (0.67)                                     0               14              0               0
  Heidelberg                                                                  JF6X01.0022                                                   151 (1.26)                                        18                   16                                    10.60                                                                 2.10 (1.21-3.48); 0.01                                                             JF6X01.0015 ARS                                                       30 (1.44)                                     3               25              0               2
  Newport                                                                     JJPX01.0011                                                    54 (0.45)                                         0                   0                                       0                                                                   0.00 (0.00-1.00); 0.05                                                             JJPX01.0204 ARS                                                        1 (0.05)                                     0               1               0               0
  Newport                                                                     JJPX01.0061                                                    72 (0.60)                                        28                   0                                       0                                                                   0.00 (0.00-0.74); 0.02                                                             JJPX01.0069 ARS                                                        1 (0.05)                                     0               0               1               0
  Thompson                                                                    JP6X01.0001                                                    54 (0.45)                                         0                   3                                      5.56                                                                 1.03 (0.25-2.95); 0.90                                                             JP6X01.0024 ARS                                                        1 (0.05)                                     0               1               0               0
  Typhimurium                                                                 JPXX01.0001                                                    53 (0.44)                                         2                   3                                      5.66                                                                 1.05 (0.26-3.02); 0.87                                                             JPXX01.0021 ARS                                                        1 (0.05)                                     0               1               0               0
  Typhimurium                                                                 JPXX01.0003                                                   113 (0.94)                                         2                   9                                      7.96                                                                 1.52 (0.72-2.91); 0.24                                                             JPXX01.0003 ARS                                                       18 (0.86)                                     6               5               3               4
  Typhimurium                                                                 JPXX01.0018                                                    81 (0.68)                                         0                   2                                      2.47                                                                 0.44 (0.07-1.51); 0.24                                                             JPXX01.0002 ARS                                                        2 (0.10)                                     1               0               1               0
  Typhimurium                                                                 JPXX01.0146                                                   278 (2.32)                                        16                   1                                      0.36                                                                 0.06 (0.00-0.31); 0.00                                                             JPXX01.0081 ARS                                                        5 (0.24)                                     0               1               4               0
  Typhimurium                                                                 JPXX01.0302                                                   149 (1.25)                                        46                   3                                      2.01                                                                 0.36 (0.09-0.99); 0.05                                                             JPXX01.0106 ARS                                                        2 (0.10)                                     1               1               0               0
  Typhimurium                                                                 JPXX01.0604                                                    61 (0.51)                                         3                   1                                      1.64                                                                 0.29 (0.01-1.49); 0.18                                                             JPXX01.0079 ARS                                                       10 (0.48)                                     1               7               0               2
  Typhimurium;I 4,[@pone.0077836-GernerSmidt1],12:i:-                         JPXX01.0026                                                    61 (0.51)                                         4                   1                                      1.64                                                                 0.29 (0.01-1.49); 0.18                                                     JPXX01.0308 ARS; TERX01.0010 ARS                                                  0                                         0               0               0               0
  I 4,[@pone.0077836-GernerSmidt1],12:i:-                                     JPXX01.0621                                                   219 (1.83)                                         2                   8                                      3.65                                                                 0.66 (0.30-1.28); 0.25                                                             TERX01.0001 ARS                                                       15 (0.72)                                     2               12              1               0
  Typhimurium;I 4,[@pone.0077836-GernerSmidt1],12:i:-                         JPXX01.1212                                                    47 (0.39)                                         0                   3                                      6.38                                                                 1.20 (0.29-3.45); 0.72                                                     JPXX01.0304 ARS; TERX01.0008 ARS                                                  0                                         0               0               0               0
  TOTAL                                                                                                                                    4,722 (39.46)                                      251                 271                                      NA                                                                                                                                                          TOTAL                                                           275 (13.20)                                   16              238              10             11

Pattern names include a three-letter code that indicates serotype (e.g., JEG for serotype Enteritidis in the pattern names JEGX01.0004 and JEGA26.0002), followed by a three-character code for.

restriction enzyme (e.g., X01 for XbaI in JEGX01.0004; A26 for BlnI in JEGA26.0002), and a four-digit number for the unique strain designation (e.g., 0004 in JEGX01.0004) (Gerner-Smidt et al., 2006).

Percentage of total number of human *Salmonella* isolates (11,967).

Number of human *Salmonella* isolates recovered from blood for a particular pattern expressed as a percentage of the total number from all sources for that PFGE pattern; e.g., for Berta XbaI.

pattern JAXX01.0001, (5/49)×100 = 10.20%. Statistical method for determining Odds Ratio is described in Materials and Methods.

VetNet's pattern nomenclature conforms to PulseNet's nomenclature, with three exceptions: (1) PulseNet uses a single three-letter code (JPX) to designate both serotype Typhimurium and antigenic formula I 4,[@pone.0077836-GernerSmidt1],12:i:- whereas VetNet uses two different codes, JPX for Typhimurium and TER for I 4,[@pone.0077836-GernerSmidt1],12:i:-; (2) the four-digit strain designation codes are different in the two systems; and (3) "ARS" (for Agricultural Research Service of the USDA) is appended to VetNet pattern names.

Percentage of the total number of animal *Salmonella* isolates (2,083).

VetNet identified two different patterns within PulseNet pattern JEGX01.0021.

Sixteen (80%) of the 20 most common human *Salmonella* patterns shown in [Fig. 1](#pone-0077836-g001){ref-type="fig"} were also found among the 2,083 food animal *Salmonella* isolates ([Table 2](#pone-0077836-t002){ref-type="table"}). A total of 4,235 (35%) of the 11,967 human *Salmonella* isolates shared these 16 PFGE patterns with 275 (13%) of the 2,083 food animal *Salmonella* isolates. All six serotypes and the antigenic formula identified in the 20 most common human *Salmonella* patterns were also represented among the shared common patterns.

The most frequently observed shared common pattern from human *Salmonella* isolates was Enteritidis pattern JEGX01.0004 (JEGX01.0003ARS), which accounted for 16% of all human *Salmonella*. Among food animal *Salmonella*, this pattern was the second most common pattern, accounting for 5% of all food animal *Salmonella* isolates. Serotype Kentucky pattern JGPX01.0027 (JGPX01.0220 ARS) was the most common PFGE pattern in food animal *Salmonella*, occurring in 13% of food animal *Salmonella* isolates (data not shown). This pattern was rarely seen in BOL human *Salmonella* isolates (0.25%).

Of the 275 food animal *Salmonella* isolates with shared common patterns, 238 (87%) were recovered from chicken, 16 (6%) from cattle, 11 (4%) from turkey and 10 (4%) from swine ([Table 2](#pone-0077836-t002){ref-type="table"}). Sixty seven percent (n = 186) of these 275 food animal *Salmonella* isolates belonged to serotype Enteritidis, and all but two isolates were recovered from chicken. The most common Enteritidis pattern in *Salmonella* from chickens was JEGX01.0004 (JEGX01.0003ARS) (n = 105/184; 57%). Chicken was also the most common source of Heidelberg pattern JF6X01.0022 (JF6X01.0015 ARS), with 25 of 30 isolates (83%) recovered from chicken ([Table 2](#pone-0077836-t002){ref-type="table"}).

In contrast to the strong association of S. Enteritidis and Heidelberg patterns with chicken, Typhimurium pattern JPXX01.0003 (JPXX01.0003 ARS) (n = 18) was observed in *Salmonella* recovered in comparable numbers from cattle (n = 6), chicken (n = 5), turkey (n = 4) and swine (n = 3). The second most common food animal Typhimurium pattern, JPXX01.0604 (JPXX01.0079 ARS) (n = 10) was primarily recovered from chicken (n = 7). The two isolates of pattern JPXX01.0018 (JPXX01.0002 ARS) were recovered from cattle and swine, respectively, and Typhimurium pattern JPXX01.0146 (JPXX01.0081 ARS) (n = 5) was recovered primarily from swine (n = 4). Berta pattern JAXX01.0001 (JAXX01.0003 ARS) (n = 3) was found exclusively in turkey.

All 16 shared common patterns were found in human *Salmonella* during each of the seven years of the study. Three of the 16 shared common patterns, Enteritidis patterns JEGX01.0004 (JEGX01.0003 ARS), JEGX01.0005 (JEGX01.0002 ARS) and JEGX01.0034 (JEGX01.0005 ARS), were also found in food animal *Salmonella* during each of the seven years of the study. Similarly, Heidelberg pattern JF6X01.0022 (JF6X01.0015 ARS) was recovered from food animals in each of five years, and Typhimurium pattern JPXX01.0003 (JPXX01.0003 ARS) in each of four years (data not shown).

Unshared PFGE Patterns {#s3c}
----------------------

A total of 261 different patterns were identified among the 11,967 human *Salmonella* isolates in Pennsylvania, and 794 were identified among the 2,083 food animal *Salmonella* isolates (data not shown). Many of the identified human patterns were not shared by food animal *Salmonella* isolates, and many of the identified food animal *Salmonella* patterns were not shared by human *Salmonella* isolates. Of the 2,083 food animal *Salmonella* isolates, only 1,034 (50%) shared PFGE patterns with the human *Salmonella* patterns that had been assigned pattern names. Of the 11,967 human *Salmonella* isolates, only 5,266 (44%) had named patterns found among the 2,083 food animal *Salmonella* isolates recovered from northeastern slaughter and processing facilities.

Of the 20 most common human *Salmonella* patterns ([Fig. 1](#pone-0077836-g001){ref-type="fig"} and [Table 2](#pone-0077836-t002){ref-type="table"}), two Enteritidis patterns (JEGX01.0002 and JEGX01.0009) and two Typhimurium/I 4,[@pone.0077836-GernerSmidt1],12:i:- patterns (JPXX01.0026 and JPXX01.1212) were not observed among food animal *Salmonella* isolates. Pattern JEGX01.0002 was found to be associated with travel. Travel histories were available for 200 persons associated with *Salmonella* pattern JEGX01.0002; of these, 164 (82%) reported traveling outside the U.S., notably to the Dominican Republic (n = 71) and Mexico (n = 53).

Association of Invasiveness with PFGE Patterns {#s3d}
----------------------------------------------

Isolation from blood was used as an indicator of invasiveness. A total of 646 *Salmonella* isolates from humans were recovered from blood, representing 5.4% of the 11,967 human *Salmonella* isolates tested ([Table 2](#pone-0077836-t002){ref-type="table"}). Four patterns were found to be significantly associated with increased frequency of isolation from blood: Enteritidis JEGX01.0004 (JEGX01.0003 ARS) (OR = 1.30; p = 0.01), Enteritidis JEGX01.0005 (JEGX01.0002 ARS) (OR = 1.60; p = 0.014), Enteritidis JEGX01.0009 (JEGX01.0022 ARS) (OR = 2.06; p = 0.02) and Heidelberg JF6X01.002 (JF6X01.0015 ARS) (OR = 2.10; p = 0.01). Five patterns were found to be significantly associated with decreased frequency of isolation from blood: Enteritidis JEGX01.0034 (JEGX01.0005 ARS) (OR = 0.10; p = 0.00), Newport patterns JJPX01.0011 (JJPX01.0204 ARS) (OR = 0.00; p = 0.05) and JJPX01.0061 (JJPX01.0069 ARS) (OR = 0.00; p = 0.02), and Typhimurium patterns JPXX01.0146 (JPXX01.0081 ARS) (OR = 0.06; p = 0.00) and JPXX01.0302 (JPXX01.0106 ARS) (OR = 0.36; p = 0.05).

Antimicrobial Susceptibility Associated with Shared Common Patterns {#s3e}
-------------------------------------------------------------------

Of the 4,235 human *Salmonella* isolates with shared common patterns, 467 (11%) were tested for susceptibility to antimicrobial agents ([Table 3](#pone-0077836-t003){ref-type="table"}). Of these 467, a total of 367 (79%) were pansusceptible, 100 (21%) were resistant to at least one class of antimicrobial agent, 75 (16%) were MDR, and 62 (13%) were resistant to five or more classes of antimicrobial agents. Of the 275 food animal *Salmonella* isolates, 226 (82%) were pansusceptible, 49 (18%) were resistant to at least one class of antimicrobial agents, 40 (14%) were MDR, and 16 (6%) were resistant to five or more classes of antimicrobial agents.

10.1371/journal.pone.0077836.t003

###### Antimicrobial resistance associated with the 16 most common human *Salmonella* PFGE patterns shared by food animal *Salmonella*.

![](pone.0077836.t003){#pone-0077836-t003-3}

  Human *Salmonella*                         Food Animal *Salmonella*                                                                                                                                                                                             
  ----------------------------------------- -------------------------- ----- ------------ ---------- ----------- ----------- --- --- ----------------------------------------------------------------- ----- ------------ ----------- ----------- ----------- --- ----
  Berta                                            JAXX01.0001          16     9 (56.3)    2 (12.5)   5 (31.3)     1 (6.3)    1   2                           JAXX01.0003 ARS                            3     0 (0.0)      0 (0.0)    3 (100.0)    0 (0.0)    0   1
  Enteritidis                                      JEGX01.0004          114   108 (94.7)   5 (4.4)     1 (0.9)     0 (0.0)    1   0                           JEGX01.0003 ARS                           106   103 (97.2)    3 (2.8)     0 (0.0)     0 (0.0)    0   0
  Enteritidis                                      JEGX01.0005          25    25 (100.0)   0 (0.0)     0 (0.0)     0 (0.0)    0   0                           JEGX01.0002 ARS                           65    65 (100.0)    0 (0.0)     0 (0.0)     0 (0.0)    0   0
  Enteritidis                                      JEGX01.0021          33    27 (81.8)    6 (7.3)     0 (0.0)     0 (0.0)    0   0   JEGX01.0010 ARS JEGX01.0052 ARS[4](#nt113){ref-type="table-fn"}    1     0 (0.0)     1 (100.0)    0 (0.0)     0 (0.0)    0   0
  Enteritidis                                      JEGX01.0034          22    21 (95.5)    1 (4.5)     0 (0.0)     0 (0.0)    0   0                           JEGX01.0005 ARS                           14    12 (85.7)    2 (14.3)     0 (0.0)     0 (0.0)    0   0
  Heidelberg                                       JF6X01.0022          14    13 (92.9)    0 (0.0)     1 (7.1)     0 (00.)    0   1                           JF6X01.0015 ARS                           30    18 (60.0)     2 (6.7)    10 (33.3)    0 (0.0)    0   10
  Newport                                          JJPX01.0011           9    9 (100.0)    0 (0.0)     0 (0.0)     0 (0.0)    0   0                           JJPX01.0204 ARS                            1    1 (100.0)     0 (0.0)     0 (0.0)     0 (0.0)    0   0
  Newport                                          JJPX01.0061          13    13 (100.0)   0 (0.0)     0 (0.0)     0 (00.)    0   0                           JJPX01.0069 ARS                            1    1 (100.0)     0 (0.0)     0 (0.0)     0 (0.0)    0   0
  Thompson                                         JP6X01.0001           8     8 (100)     0 (0.0)     0 (0.0)     0 (0.0)    0   0                           JP6X01.0024 ARS                            1    1 (100.0)     0 (0.0)     0 (0.0)     0 (0.0)    0   0
  Typhimurium                                      JPXX01.0001          13    10 (76.9)    1 (7.7)    2 (15.4)     1 (7.7)    0   1                           JPXX01.0021 ARS                            1    1 (100.0)     0 (0.0)     0 (0.0)     0 (0.0)    0   0
  Typhimurium                                      JPXX01.0003          38     0 (0.0)     1 (2.6)    37 (97.4)   37 (97.4)   0   0                           JPXX01.0003 ARS                           18     0 (0.0)      1 (5.6)    17 (94.4)   14 (78.0)   0   0
  Typhimurium                                      JPXX01.0018          27     0 (0.0)     2 (7.4)    25 (92.6)   23 (85.2)   0   0                           JPXX01.0002 ARS                            2     0 (0.0)      0 (0.0)    2 (100.0)   2 (100.0)   0   0
  Typhimurium                                      JPXX01.0146          24    23 (95.8)    1 (4.2)     0 (0.0)     0 (0.0)    0   0                           JPXX01.0081 ARS                            5    5 (100.0)     0 (0.0)     0 (0.0)     0 (0.0)    0   0
  Typhimurium                                      JPXX01.0302          22    20 (90.9)    1 (4.5)     1 (4.5)     0 (0.0)    1   0                           JPXX01.0106 ARS                            2    2 (100.0)     0 (0.0)     0 (0.0)     0 (0.0)    0   0
  Typhimurium                                      JPXX01.0604          13    13 (100.0)   0 (0.0)     0 (0.0)     0 (0.0)    0   0                           JPXX01.0079 ARS                           10    10 (100.0)    0 (0.0)     0 (0.0)     0 (0.0)    0   0
  I 4,[@pone.0077836-GernerSmidt1],12:i:-          JPXX01.0621          76    68 (89.5)    5 (6.6)     3 (3.9)     0 (0.0)    0   1                           TERX01.0001 ARS                           15     7 (46.7)     0 (0.0)    8 (53.3)     0 (0.0)    0   7
  TOTAL                                                                 467   367 (78.6)   25 (5.4)   75 (16.1)   62 (13.3)   3   5                                TOTAL                                275   226 (82.2)    9 (3.3)    40 (14.5)   16 (5.8)    0   18

Typhimurium includes var. O5-.

Resistant to at least three classes of antimicrobial agents.

Abbreviations: nalidixic acid (Nal); ceftriaxone (Axo).

VetNet identified two different patterns within PulseNet pattern JEGX01.0021.

Based on 467 isolates tested for antimicrobial susceptibility.

Based on 275 isolates tested for antimicrobial susceptibility.

Antimicrobial classes (antimicrobial agents in parentheses; resistance breakpoints in brackets): aminoglycosides (amikacin \[≥64 µg/mL\], gentamicin \[≥16 µg/mL\], kanamycin \[≥64 µg/mL\] and streptomycin \[≥64 µg/mL\]), ß-lactam/ß-lactamase inhibitor combinations (amoxicillin/clavulanic acid \[≥32/16 µg/mL\]), cephems (cefoxitin \[≥32 µg/mL\], ceftiofur \[≥8 µg/mL\] and ceftriaxone \[≥4 µg/mL\]), penicillins (ampicillin \[≥32 µg/mL\]), quinolones (ciprofloxacin \[≥4 µg/mL\]and nalidixic acid \[≥32 µg/mL\]), folate pathway inhibitors (sulfisoxazole \[≥512 µg/mL\], trimethoprim/sulfamethoxazole \[≥4/76 µg/mL\]), phenicols (chloramphenicol \[≥32 µg/mL\]), and tetracyclines (tetracycline \[≥16 µg/mL\]).

Multidrug resistance (resistance to ≥3 classes of antimicrobial agents) was associated with eight of the 16 shared common patterns in human *Salmonella* ([Table 3](#pone-0077836-t003){ref-type="table"}). Five of these patterns were also associated with multidrug resistance in food animal *Salmonella*: Berta pattern JAXX01.0001 (JAXX01.0003 ARS), Heidelberg pattern JF6X01.0022 (JF6X01.0015 ARS), Typhimurium patterns JPXX01.0003 (JPXX01.0003 ARS) and JPXX01.0018 (JPXX01.0002 ARS), and I 4,[@pone.0077836-GernerSmidt1],12:i:- pattern JPXX01.0621 (TERX01.0001 ARS). The incidence of multidrug resistance in both human and food animal *Salmonella* isolates exceeded 90% for Typhimurium patterns JPXX01.0003 (JPXX01.0003 ARS) and JPXX01.0018 (JPXX01.0002 ARS) ([Table 3](#pone-0077836-t003){ref-type="table"}), patterns that differ by two bands ([Fig. 1](#pone-0077836-g001){ref-type="fig"}). When these two patterns were considered together, a total of 58 (89%) of the 65 human and 15 (75%) of the 20 food animal Typhimurium isolates were resistant to the following five antimicrobial agents: ampicillin, chloramphenicol, streptomycin, sulfisoxazole, and tetracycline (the ACSSuT phenotype and resistance to five classes of antimicrobial agents). Two of the human *Salmonella* isolates exhibited resistance to amoxicillin/clavulanic acid and ceftiofur in addition to the ACSSuT phenotype. The food animal *Salmonella* isolates exhibiting the ACSSuT phenotype were recovered from cattle (n = 5), chickens (n = 4), swine (n = 3) and turkeys (n = 3). An additional isolate recovered from a turkey exhibited the ACSSuT phenotype plus resistance to gentamicin, and three additional isolates (two from cattle; one from swine) lacked only the streptomycin resistance of this phenotype (ACSuT). One human isolate and three food animal isolates with patterns JPXX01.0003 (JPXX01.0003 ARS) and JPXX01.0018 (JPXX01.0002 ARS) were resistant only to streptomycin and sulfisoxazole. Collectively Typhimurium patterns JPXX01.0003 (JPXX01.0003 ARS) and JPXX01.0018 (JPXX01.0002 ARS) were associated with resistance to five or more classes of antimicrobial agents in 60 (92%) of the 65 human *Salmonella* and 16 (80%) of the 20 food animal *Salmonella*.

Of the 15 food animal *Salmonella* isolates exhibiting I 4,[@pone.0077836-GernerSmidt1],12:i:- pattern JPXX01.0621 (TERX01.0001 ARS), seven were resistant to amoxicillin/clavulanic acid, ampicillin, cefoxitin, ceftiofur and ceftriaxone. Of the 76 susceptibility-tested human *Salmonella* isolates exhibiting patternJPXX01.0621 (TERX01.0001 ARS), only one exhibited the exact resistance pattern. A second human *Salmonella* isolate exhibited a closely related resistance profile: the isolate was intermediate instead of resistant to ceftriaxone. The resistance patterns of the additional MDR food animal *Salmonella* isolates and human *Salmonella* isolate with pattern JPXX01.0621 (TERX01.0001 ARS) did not match.

Although we did not find resistance to the fluoroquinolone ciprofloxacin in any human or food animal *Salmonella* isolate, three human *Salmonella* isolates, Berta pattern JAXX01.0001, Enteritidis pattern JEGX01.0004 (JEGX01.0003 ARS) and Typhimurium pattern JPXX01.0302 (JPXX01.0106 ARS), were resistant to nalidixic acid (Nal), an indicator of decreasing susceptibility to quinolones [@pone.0077836-Centers1].

Invasiveness and Antimicrobial Resistance to Antimicrobial Agents {#s3f}
-----------------------------------------------------------------

Of the 467 human *Salmonella* isolates tested for antimicrobial susceptibility, 367 were pansusceptible, and 100 were resistant to one or more antimicrobial agents ([Table 3](#pone-0077836-t003){ref-type="table"}). Twelve (3.2%) of the 367 pansusceptible isolates and 10 (10%) of the 100 isolates resistant to one or more antimicrobial agents were recovered from blood. This difference was found to be significant (p = 0.0129). Included among the 10 resistant blood isolates were four Typhimurium pattern JPXX01.0003 (JPXX01.0003 ARS) isolates, two Enteritidis pattern JEGX01.0021 (JEGX01.0010 ARS and JEGX01.0052 ARS), one each of Typhimurium patterns JPXX01.0018 (JPXX01.0002 ARS) and JPXX01.0146 (JPXX01.0081 ARS), one Berta pattern JAXX01.0001 (JAXX01.0003 ARS ), and one nalidixic acid-resistant Enteritidis pattern JEGX01.0004 (JEGX01.0003 ARS).

Discussion {#s4}
==========

We compared clinical isolates of *Salmonella* recovered from ill humans received as part of routine operations in Pennsylvania during 2005-2011 with *Salmonella* isolates collected during the same period from food animals at federally inspected slaughter and processing facilities in the northeastern U.S. We also correlated PFGE patterns of *Salmonella* from humans with animal sources, invasiveness, and antimicrobial susceptibility profiles. Our analysis was based on the most common human *Salmonella* PFGE patterns identified during this period, regardless of serotype. This approach differs from many studies because of its focus on PFGE patterns rather than serotypes and on PFGE patterns that are frequently observed with sporadic disease, rather than solely on patterns linked to outbreaks. However, it is important to note that outbreak isolates were a portion of the overall number of isolates in this study. This is the first study to compare the PFGE patterns of human *Salmonella* isolates recovered during routine surveillance with food animal *Salmonella* isolates recovered at federally inspected slaughter and processing facilities. We found that subtyping *Salmonella* isolates by PFGE revealed differences within serotypes in terms of antimicrobial susceptibility patterns and, for human *Salmonella*, differences in food animal sources and invasiveness that were not evident from serotyping alone.

We found that most (16) but not all of the 20 most common PFGE patterns identified in human *Salmonella* in Pennsylvania were also found in *Salmonella* recovered from food animals in the northeast. The fact that some patterns within a particular serotype were observed in human *Salmonella* but not food animal *Salmonella* and vice versa demonstrates the utility of subtyping isolates within a serotype. Others have previously demonstrated PFGE pattern diversity within a serotype [@pone.0077836-Adaska1]-[@pone.0077836-Zou1], but such diversity is a critical observation that is often overlooked. PFGE pattern diversity may explain why morbidity and mortality vary within a serotype and could be useful in assessing the effectiveness of control measures.

Further, the absence of some of the most common human *Salmonella* PFGE patterns from food animal *Salmonella* isolates suggests that sources other than food animals play a role in clinical illness: e.g., fresh produce, nuts and other foods [@pone.0077836-Centers2], [@pone.0077836-PainterJA1], suggesting that there is a vast biodiversity associated with food production that is often overlooked.

Although chickens represented only 14.7% of the 65,655 food animals tested, they represented 54.6% of the 2,187 food animals that were positive for *Salmonella* and were the source of 87% of the isolates with shared common patterns. Chicken consumption has been recognized as one of the risk factors for developing salmonellosis caused by serotypes Enteritidis [@pone.0077836-Altekruse1]-[@pone.0077836-Marcus1] and Heidelberg [@pone.0077836-Currie1], and our PFGE results support these associations. Enteritidis pattern JEGX01.0004 (JEGX01.0003 ARS) was the most common human *Salmonella* pattern in Pennsylvania, accounting for 1,968 (16%) of the 11,967 human Salmonella isolates and 130 (20%) of the 646 invasive salmonellosis cases. The presence of *Salmonella* Enteritidis pattern JEGX01.0004 (JEGX01.0003) in chickens during every year of this study suggests the potential for a significant impact on public health and requires further investigation to determine what attributes sustain the persistence of this strain and what measures could reduce its incidence. This further supports our assertion that consideration of strain diversity (i.e., PFGE pattern diversity) is a critical factor for developing control measures.

The frequent occurrence of human salmonellosis associated with pattern JEGX01.0004 (JEGX01.0003 ARS) makes case investigations difficult unless there is a strong epidemiological connection linking the cases. Lacking such a connection, salmonellosis cases associated with this pattern are generally given less scrutiny by epidemiologists, in spite of the fact that the number of cases associated with this pattern in Pennsylvania (n = 1,968) is much greater than the number of identified outbreak-associated isolates for all patterns combined (n = 251) ([Table 2](#pone-0077836-t002){ref-type="table"}). S. Enteritidis pattern JEGX01.0004 (JEGX01.0003 ARS) was associated with a national outbreak involving approximately 1,939 illnesses [@pone.0077836-Centers3] and recalls of more than 500 million shell eggs [@pone.0077836-Allard1]. New regulations governing egg safety in the U.S. [@pone.0077836-Food1] may help to reduce the incidence of salmonellosis associated with pattern JEGX01.0004 (JEGX01.0003 ARS). However, since our study has demonstrated seven years of this pattern's high level of persistence in poultry meat, it is reasonable to conclude that *Salmonella* Enteritidis pattern JEGX01.0004 (JEGX01.0003 ARS) is persistent and endemic in poultry. Efforts focused on reducing *Salmonella* in broiler flocks have met with very encouraging results in Denmark [@pone.0077836-Anonymous1], [@pone.0077836-Wegener1] and the United Kingdom [@pone.0077836-OBrien1]. Data collected in the coming years will provide critical information regarding the potential reduction of *Salmonella* Enteritidis pattern JEGX01.0004 (JEGX01.0003 ARS) in the United States.

Eleven of the 16 shared PFGE patterns were associated with susceptibility to all antimicrobial agents tested or resistance to fewer than three classes of antimicrobial agents in food animal *Salmonella* ([Table 3](#pone-0077836-t003){ref-type="table"}). This is encouraging from an antimicrobial resistance perspective, indicating that not all PFGE subtypes and serotypes acquire the same degree or type of resistance. Multidrug resistance was associated with Berta pattern JAXX01.0001 (JAXX01.0003 ARS), Heidelberg pattern JF6X01.0022 (JF6X01.0015 ARS), Typhimurium patterns JPXX01.0003 (JPXX01.0003 ARS) and JPXX01.0018 (JPXX01.0002 ARS), and I 4,[@pone.0077836-GernerSmidt1],12:i:- pattern JPXX01.0621 (TERX01.0001 ARS) in both human and food animal *Salmonella*. The high degree of correspondence between PFGE patterns and antimicrobial resistance profiles for Typhimurium patterns JPXX01.0003 (JPXX01.0003 ARS) and JPXX01.0018 (JPXX01.0002 ARS) in human and food animal *Salmonella* isolates contributes to the existing body of evidence linking contaminated food and human salmonellosis. Supporting this correlation is the fact that ACSSuT-associated *Salmonella* pattern JPXX01.0003 (JPXX01.0003 ARS) was linked to a 2003 outbreak of *Salmonella-*contaminated ground beef [@pone.0077836-Dechet1]. The broad representation of MDR patterns JPXX01.0003 (JPXX01.0003 ARS) and JPXX01.0018 (JPXX01.0002 ARS) in all four types of food animals contrasts sharply with the strong association of most other patterns with chicken ([Table 2](#pone-0077836-t002){ref-type="table"}), although this may be confounded by differences in the number of animals of each type that were tested ([Table 1](#pone-0077836-t001){ref-type="table"}). Monitoring the incidence of these patterns and their associated resistance phenotypes could aid in assessing the effect of efforts to reduce the use of antimicrobial agents for growth promotion and disease prevention in food animals on public health.

Differences in the percentage of blood isolates representing each pattern suggest that there may be differences in invasiveness among *Salmonella* having different patterns, even for patterns within a serotype. Further work is needed to determine why certain patterns were associated with increased or decreased invasiveness.

In our sample of 467 human *Salmonella* isolates that were tested for susceptibility to antimicrobial agents, we did not observe a direct correlation between resistance and invasiveness within specific PFGE patterns; however, we did find that the percentage of antimicrobial-resistant isolates that were recovered from blood (10%) was approximately three times the percentage found to be pansusceptible (3.2%; p = 0.0129). Further work is needed to confirm this correlation.

For some of the four unshared common patterns, sources other than food animals slaughtered or processed in northeastern U.S. facilities are likely. For example, we found that S. Enteritidis pattern JEGX01.0002 was associated with travel outside the U.S., especially to the Dominican Republic and Mexico. Another common human *Salmonella* pattern that was not noted in food animal *Salmonella* isolates, Enteritidis pattern JEGX01.0009, has been associated with imported food: *Salmonella* with this pattern has been recovered from shrimp imported from Bangladesh and pompano from Taiwan (PulseNet national PulseNet *Salmonella* database was searched on 2012-06-11 and included data uploaded between 2008-06-12 and 2012-06-11).

In some cases, the absence of common human *Salmonella* PFGE patterns in food animal *Salmonella* may have resulted from testing an insufficient number of animals. From 2005 through 2011, the number of food animals tested for *Salmonella* in northeastern slaughter and processing facilities declined by more than half--from 13,834 in 2005 to 6,381 in 2011. Although Typhimurium pattern JPXX01.1212 and I 4,[@pone.0077836-GernerSmidt1],12:i:- pattern JPXX01.0026 were not observed in our sample of food animal *Salmonella,* they have repeatedly been observed in *Salmonella* recovered from chicken (PulseNet data; searches of the PulseNet national *Salmonella* database were conducted on 2012-06-11 and included data uploaded between 2008-06-12 and 2012-06-11). The absence of these patterns in *Salmonella* recovered from food animals in the northeast may simply reflect the limited amount of testing during the study period. Alternatively, the food responsible for illness may have come from outside the northeastern U.S., as some of the patterns have been observed in food animals from other areas in the U.S. (data not shown).

Limitations {#s4a}
-----------

This study has several limitations. The first is the absence of data for testing food animal *Salmonella* isolates with a second-enzyme (BlnI). Testing human *Salmonella* isolates with BlnI has helped to discriminate within most PFGE patterns produced with XbaI. Beginning in 2011, VetNet specimens have been tested with BlnI, so this information will be available for future studies. A second limitation is the reduced number of samples collected by FSIS for *Salmonella* testing at federally inspected slaughter and processing plants in the northeast in recent years. A third limitation is the fact that only 11% of the human *Salmonella* isolates with the 16 common shared PFGE patterns were tested for susceptibility to antimicrobial agents. Finally, we recognize that not all food slaughtered and processed in a particular geographic region is consumed in the same region and that different regions of the U.S. vary in their poultry production concentrations.

Conclusions {#s5}
===========

This work shows that 16 of the 20 most common PFGE patterns found in human *Salmonella* in Pennsylvania were also found in *Salmonella* recovered from food animals sampled at federally inspected slaughter and processing facilities in the northeastern U.S. Multidrug resistance was correlated with five PFGE patterns shared by food animal and human *Salmonella*: Berta pattern JAXX01.0001 (JAXX01.0003 ARS), Heidelberg pattern JF6X01.0022 (JF6X01.0015 ARS), Typhimurium patterns JPXX01.0003 (JPXX01.0003 ARS) and JPXX01.0018 (JPXX01.0002 ARS), and I 4,[@pone.0077836-GernerSmidt1],12:i:- pattern JPXX01.0621 (TERX01.0001 ARS). The most common human pattern, *S*. Enteritidis patterns JEGX01.0004 (JEGX01.0003 ARS), accounting for 16% of all human *Salmonella*, was also common in *Salmonella* recovered from food animals, especially chicken. Our findings suggest an association between the most prevalent forms of human salmonellosis and contaminated meat and poultry. They also show a persistence of Enteritidis pattern JEGX01.0004 (JEGX01.0003 ARS), the association of differences in invasiveness with different PFGE patterns, and the tendency for some but not all PFGE subtypes within a serotype to acquire multidrug resistance. Comparing the PFGE fingerprint patterns and antimicrobial susceptibility profiles of *Salmonella* from humans with those from food animals inspected in slaughter and processing facilities located in a specific geographic region provides information that may assist in source attribution and outbreak investigations.

We acknowledge important contributions from the following partners: Todd A. Lauze, U.S. Department of Agriculture, Food Safety and Inspection Service, Eastern Laboratory, Athens, Georgia, USA, for providing the food animal sampling data in Table 1; Kirsten Waller, Pennsylvania Department of Health Bureau of Epidemiology, USA, for providing the outbreak data for Table 2 and assistance with statistical analysis; FDA for PFGE testing of *Salmonella* whose patterns matched those of some common human PFGE patterns not shared by food animal *Salmonella*; CDC PulseNet for assigning PFGE pattern names; BOL Bacteriology Section for identifying and serotyping human *Salmonella*; BOL Molecular Microbiology Section for PFGE testing.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: Conceived and designed the experiments: CHS PJF-C. Performed the experiments: CHS DT KJ. Analyzed the data: CHS PJF-C SO NMM. Wrote the paper: CHS PJF-C DT KJ SO NMM.
